These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 20156514

  • 1. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.
    Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, Innami T, Sasaki A, Hineno T, Sakamoto T, Inami Y, Nakamura Y, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):522-6. PubMed ID: 20156514
    [Abstract] [Full Text] [Related]

  • 2. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2008 Jul 16; 9(5):537-41. PubMed ID: 18276187
    [Abstract] [Full Text] [Related]

  • 3. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.
    J Neurol Sci; 2010 Jul 15; 294(1-2):62-6. PubMed ID: 20451927
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
    Oertel WH, Stiasny-Kolster K, Bergtholdt B, Hallström Y, Albo J, Leissner L, Schindler T, Koester J, Reess J, Pramipexole RLS Study Group.
    Mov Disord; 2007 Jan 15; 22(2):213-9. PubMed ID: 17133582
    [Abstract] [Full Text] [Related]

  • 5. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2009 Jun 15; 10(6):630-6. PubMed ID: 19171500
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2006 Aug 15; 7(5):407-17. PubMed ID: 16815748
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.
    Sleep Med; 2010 Jan 15; 11(1):11-6. PubMed ID: 19962941
    [Abstract] [Full Text] [Related]

  • 8. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.
    Sleep Med; 2008 Dec 15; 9(8):874-81. PubMed ID: 18952497
    [Abstract] [Full Text] [Related]

  • 9. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G, Dolso P, Canesin R, Cancelli I, Valente M, Gigli GL.
    Neuropsychobiology; 2006 Dec 15; 54(3):195-200. PubMed ID: 17314491
    [Abstract] [Full Text] [Related]

  • 10. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K, Oertel WH.
    Neuropsychobiology; 2004 Dec 15; 50(1):65-70. PubMed ID: 15179023
    [Abstract] [Full Text] [Related]

  • 11. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, Ferini-Strambi L.
    Sleep Med; 2007 Aug 15; 8(5):491-7. PubMed ID: 17512780
    [Abstract] [Full Text] [Related]

  • 12. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B.
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug 15; 252(4):185-94. PubMed ID: 12242580
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S, Abrams KR, Nicolas A, Martin M, Petit C, Lleu PL, Finnern HW.
    Sleep Med; 2008 Oct 15; 9(7):715-26. PubMed ID: 18226947
    [Abstract] [Full Text] [Related]

  • 14. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
    Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J.
    Mov Disord; 2006 Sep 15; 21(9):1404-10. PubMed ID: 16755554
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of pramipexole in restless legs syndrome.
    Winkelman JW, Sethi KD, Kushida CA, Becker PM, Koester J, Cappola JJ, Reess J.
    Neurology; 2006 Sep 26; 67(6):1034-9. PubMed ID: 16931507
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T, Inoue Y, Nakashima K.
    J Neurol Sci; 2006 Dec 01; 250(1-2):39-44. PubMed ID: 16899256
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M, Inoue Y, Namba K, Munezawa T, Matsuura M.
    Mov Disord; 2008 Apr 30; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [Abstract] [Full Text] [Related]

  • 18. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
    Trenkwalder C, Collado Seidel V, Kazenwadel J, Wetter TC, Oertel W, Selzer R, Kohnen R.
    Mov Disord; 2003 Oct 30; 18(10):1184-9. PubMed ID: 14534925
    [Abstract] [Full Text] [Related]

  • 19. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
    Benes H.
    Sleep Med; 2006 Jan 30; 7(1):31-5. PubMed ID: 16194624
    [Abstract] [Full Text] [Related]

  • 20. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.
    Sleep Med; 2007 Nov 30; 8(7-8):742-52. PubMed ID: 17512789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.